ADITXT INC (ADTX) Stock Overview
NASDAQ:ADTX - US0070258027 - Common Stock
ADTX Key Statistics, Chart & Performance
The current stock price of ADTX is 1.07 USD. In the past month the price decreased by -5.31%. In the past year, price decreased by -99.98%.
ADTX Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 19.87 | 371.72B | ||
| AMGN | AMGEN INC | 12.84 | 150.72B | ||
| GILD | GILEAD SCIENCES INC | 14.96 | 143.64B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 23.4 | 101.65B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 63.20B | ||
| REGN | REGENERON PHARMACEUTICALS | 12.19 | 58.99B | ||
| ARGX | ARGENX SE - ADR | 82.74 | 46.94B | ||
| ONC | BEONE MEDICINES LTD-ADR | 6.14 | 41.74B | ||
| INSM | INSMED INC | N/A | 31.11B | ||
| BNTX | BIONTECH SE-ADR | N/A | 24.54B | ||
| NTRA | NATERA INC | N/A | 24.21B | ||
| BIIB | BIOGEN INC | 8.97 | 21.05B |
Related stock screener links
About ADTX
Company Profile
Aditxt, Inc. is a biotech innovation company, which engages in the development and commercialization of technologies focusing on monitoring and modulating the immune system. The company is headquartered in Richmond, Virginia and currently employs 26 full-time employees. The company went IPO on 2020-06-19. The company develops and commercializes technologies with a focus on monitoring and modulating the immune system. Its portfolio includes Adimune, Inc., developing a new class of therapeutics designed to retrain the immune system to address organ rejection, autoimmunity, and allergies; Adivir, Inc., focused on identifying, developing, and commercializing new ways to treat infectious diseases, and Pearsanta, Inc., offering personalized lab testing, backed by CLIA-certified and CAP-accredited monitoring center. Adimune, Inc's immune modulation product candidate, ADI-100, is based on the Apoptotic DNA Immunotherapy platform technology, utilizes a novel approach that mimics the way bodies naturally induce tolerance to own tissues. The company also offers electroencephalography (EEG) brain monitoring technologies and devices, including NeuroCap and NeuroEEG for telehealth and tele-neurology applications.
Company Info
ADITXT INC
737 N. Fifth Street, Suite 200
Richmond VIRGINIA 94043 US
CEO: Amro Albanna
Employees: 26
Phone: 19094880844
ADITXT INC / ADTX FAQ
What is the stock price of ADITXT INC today?
The current stock price of ADTX is 1.07 USD. The price increased by 17.57% in the last trading session.
What is the ticker symbol for ADITXT INC stock?
The exchange symbol of ADITXT INC is ADTX and it is listed on the Nasdaq exchange.
On which exchange is ADTX stock listed?
ADTX stock is listed on the Nasdaq exchange.
What is ADITXT INC worth?
ADITXT INC (ADTX) has a market capitalization of 5.33M USD. This makes ADTX a Nano Cap stock.
How many employees does ADITXT INC have?
ADITXT INC (ADTX) currently has 26 employees.
What are the support and resistance levels for ADITXT INC (ADTX) stock?
ADITXT INC (ADTX) has a support level at 0.91 and a resistance level at 1.08. Check the full technical report for a detailed analysis of ADTX support and resistance levels.
Is ADITXT INC (ADTX) expected to grow?
The Revenue of ADITXT INC (ADTX) is expected to grow by 1584.79% in the next year. Check the estimates tab for more information on the ADTX EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy ADITXT INC (ADTX) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of ADTX, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of ADTX, evaluating the profitability, health, valuation and growth aspects
- ADITXT INC (ADTX) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- ADITXT INC (ADTX) Sales and EPS estimates to see what analysts future expectations are.
- ADITXT INC (ADTX) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- ADITXT INC (ADTX) Insider and Institutional Ownership to learn about the owners and their transactions.
- ADITXT INC (ADTX) Stock Chart to make your own analysis
- ADITXT INC (ADTX) Latest news and press-releases to stay up to date.
Does ADITXT INC (ADTX) stock pay dividends?
ADTX does not pay a dividend.
When does ADITXT INC (ADTX) report earnings?
ADITXT INC (ADTX) will report earnings on 2025-11-17.
What is the Price/Earnings (PE) ratio of ADITXT INC (ADTX)?
ADITXT INC (ADTX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-28041.66).
What is the Short Interest ratio of ADITXT INC (ADTX) stock?
The outstanding short interest for ADITXT INC (ADTX) is 2.46% of its float. Check the ownership tab for more information on the ADTX short interest.
ADTX Technical Analysis
ADTX Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to ADTX. ADTX has a bad profitability rating. Also its financial health evaluation is rather negative.
ADTX Financial Highlights
Over the last trailing twelve months ADTX reported a non-GAAP Earnings per Share(EPS) of -28041.66. The EPS increased by 96.44% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -94.95% | ||
| ROE | -239.53% | ||
| Debt/Equity | 0.35 |
ADTX Forecast & Estimates
For the next year, analysts expect an EPS growth of -2096.63% and a revenue growth 1584.79% for ADTX